Skip to main content
. 2022 Sep 13;41(8):1872–1889. doi: 10.1002/nau.25040

Figure 1.

Figure 1

Patient Attrition. [1] Index date was defined as the first claim date of MIRA or AMs during the ascertainment period (January 10, 2016−September 30, 2019). [2] A gap in enrollment up to 45 days was allowed in the pre‐index, while no gap in enrollment was allowed in the post‐index period. [3] First claim observed in the identification period is for MIRA (or AM) medication, and there is absence of MIRA (or AM) claims in the pre‐index period. AM, antimuscarinic; CFI, Claims‐based Frailty Index; MIRA, mirabegron.